Current Practices in the Management of Chronic Myeloid Leukemia

摘要

A cross-sectional survey of board certified hematologists/oncologists was conducted to describe current chronic myeloid leukemia (CML) practice patterns and compare these self-reported practices with the clinical guidelines. Overall, the reported practice patterns regarding CML treatment were in accordance with guidelines; however, decisions also appear to be based on the attitudes, beliefs, and personal experience of the responding physicians.BackgroundA previous survey of physician self-reported practice patterns in the management of CML was conducted in 2005. The National Comprehensive Cancer Network and European LeukemiaNet guidelines now include nilotinib and dasatinib in their treatment algorithms for CML. To assess these new guidelines, a cross-sectional survey of US hematologists and/or oncologists was conducted in December 2010 through an online survey.